Zobrazeno 1 - 10
of 674
pro vyhledávání: '"Schröder CP"'
Autor:
Eisses B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherland., Bensch F; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Elias SG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Kuip EJM; Department of Medical Oncology, Radboud Medical Center, Nijmegen, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Vegt B; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lub-de Hooge MN; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherland.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Emmering J; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands., Arens AIJ; Department of Radiology and Nuclear Medicine, Radboud Medical Center, Nijmegen, The Netherlands., Zwezerijnen GJC; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands., Vugts DJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; c.schroder@nki.nl.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Oct 01; Vol. 65 (10), pp. 1540-1547. Date of Electronic Publication: 2024 Oct 01.
Autor:
Mourits MJE; UMC Groningen-Universiteit van Groningen, afd. Obstetrie en Gynaecologie,Groningen.; Contact: m.j.e.mourits@umcg.nl., Schröder CP; UMC Groningen-Universiteit van Groningen, afd. Medische Oncologie, Groningen.
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2024 Mar 04; Vol. 168. Date of Electronic Publication: 2024 Mar 04.
Autor:
Boers J; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Eisses B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Zwager MC; Department of Pathology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Bensch F; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., de Vries EFJ; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., den Dekker MAM; Department of Radiology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3584 Utrecht, The Netherlands., Kuip EJM; Department of Medical Oncology, Radboud Medical Center, 6500 Nijmegen, The Netherlands., van Herpen CML; Department of Medical Oncology, Radboud Medical Center, 6500 Nijmegen, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Location VU University Medical Center, 1081 Amsterdam, The Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., van der Vegt B; Department of Pathology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Menke-van der Houven van Oordt WC; Department of Medical Oncology, Amsterdam University Medical Center, Location VU University Medical Center, 1081 Amsterdam, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Department of Medical Oncology, Dutch Cancer Institute, 1066 Amsterdam, The Netherlands.
Publikováno v:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Feb 14; Vol. 14 (4). Date of Electronic Publication: 2024 Feb 14.
Autor:
Wildiers H; Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven, Belgium., Armstrong A; The Christie NHS Foundation Trust, Manchester, United Kingdom., Cuypere E; AZ Sint-Jan Burgge-Oostende AV, Ruddershove, Belgium., Dalenc F; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Dirix L; GZA ziekenhuizen Campus Sint-Augustinus, Antwerp, Belgium., Chan S; Nottingham Cancer Clinical Trials Team (NCCTT), Nottingham, United Kingdom., Marme F; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Schröder CP; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam and University Medical Center Groningen, the Netherlands., Huober J; Breast Center Cantonal Hospital St Gallen, Switzerland and Department of Gynaecology, University of Ulm, Ulm, Germany., Duhoux FP; Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium., Vuylsteke P; CHU UCL Namur, Site Sainte-Elisabeth, UCLouvain, Namur, Belgium., Jager A; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Brain E; Institut Curie-Hôpital René Huguenin, Saint-Cloud, France., Kuemmel S; Breat Unit, KEM Kliniken Essen-Mitte, Essen, Germany, Charité - Universitätsmedizin Berlin, Department of Gynecology with Breast Center, Berlin, Germany., Pápai Z; MH Egészségügyi Központ Onkológiai Osztály, Budapest, Hungary., Menke-van der Houven van Oordt CW; Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands., Perjesi L; Immutep, Budapest, Hungary., Mueller C; Clinical Development, Immutep, Berlin, Germany., Brignone C; Research & Development, Immutep, Saint-Aubin, France., Triebel F; Research & Development, Immutep, Saint-Aubin, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 01; Vol. 30 (3), pp. 532-541.
Autor:
Zwager MC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. m.c.zwager@umcg.nl., Holt-Kedde I; Department of Plastic Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Timmer-Bosscha H; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., de Bock GH; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Werker PMN; Department of Plastic Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van der Vegt B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Arjaans M; Department of Plastic Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Plastic Surgery, OLVG Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Feb; Vol. 204 (1), pp. 27-37. Date of Electronic Publication: 2023 Dec 06.
Autor:
Mileva M; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Guiot T; Department of Medical Physics, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Wimana Z; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Department of Radiopharmacy, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Deleu AL; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands., Lefebvre Y; Department of Radiology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Paesmans M; Data Center, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Stroobants S; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium., Huizing M; Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium., Aftimos P; Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Tol J; Department of Internal Medicine, Jeroen Bosch Ziekenhuis, Den Bosch, The Netherlands., Van der Graaf WTA; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Oyen WJG; Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Vugts DJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology, Amsterdam UMC Location VUMC, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Piccart-Gebhart M; Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Flamen P; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Gebhart G; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. geraldine.gebhart@hubruxelles.be.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Jan 06; Vol. 10 (1), pp. 4. Date of Electronic Publication: 2024 Jan 06.
Autor:
Chen M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Yu S; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van der Sluis T; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Zwager MC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Vegt B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. b.v.d.vegt@umcg.nl., van Vugt MATM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. m.vugt@umcg.nl.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Jan 02; Vol. 10 (1), pp. 1. Date of Electronic Publication: 2024 Jan 02.
Autor:
Schröder CP; Department Medical Oncology, Netherlands Cancer Institute Amsterdam and University Medical Center Groningen, The Netherlands., van Leeuwen-Stok E; Dutch Breast Cancer Trialists' Research Group (BOOG), The Netherlands., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Linderholm B; Department of Oncologym, Sahlgrenska University Hospital, Gothenburg, Sweden and Swedish Association of Breast Oncologists (SABO), Sweden., Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Wolff AC; Department of Medical Oncology, Johns Hopkins, Baltimore, MD, USA., Bjelic-Radisic V; Breast Unit, Helios University Clinic, Wuppertal, University Witten/Herdecke, Germany., Werutsky G; Latin American Cooperative Oncology Group, Porto Alegre, Brazil., Abreu MH; Department of Medical Oncology, Portuguese Institute of Oncology of Porto, Porto, Portugal., Bozovic-Spasojevic I; Department of Medical Oncology, Institute of Oncology and Radiology, Belgrade, Serbia., den Hoed I; Department of Medical Oncology, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands., Honkoop AH; Department of Medical Oncology, Isala, Zwolle, The Netherlands., Los M; Department of Medical Oncology, St. Antonius Ziekenhuis, Utrecht, The Netherlands., Leone JP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Russell NS; Department of Radiotherapy, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Ziekenhuis's Hertogenbosch, The Netherlands., van der Velden AWG; Department of Medical Oncology, Martini Ziekenhuis, Groningen, The Netherlands., Van Poznak C; Department of Medical Oncology, University of Michigan, Ann Arbor, MI, USA., Vleugel MM; Department of Medical Oncology, Waterlandziekenhuis, Purmerend, The Netherlands., Yung RL; Department of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Coens C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Giordano SH; Department of Health Services Research and Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Oct 03; Vol. 28 (10), pp. e877-e883.
Autor:
de Heer EC; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands., Zois CE; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk.; Department of Radiotherapy and Oncology, School of Health, Democritus University of Thrace, Alexandroupolis, Greece. christos.zois@oncology.ox.ac.uk.; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, Molecular Oncology Laboratories, John Radclife Hospital, Oxford University, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk., Bridges E; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK., van der Vegt B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Sheldon H; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK., Veldman WA; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands., Zwager MC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van der Sluis T; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Morita T; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan., Baba O; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands.; Department of Medical Oncology, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands., de Jong S; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands., Harris AL; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK., Jalving M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands. m.jalving@umcg.nl.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Aug 28; Vol. 42 (1), pp. 220. Date of Electronic Publication: 2023 Aug 28.
Autor:
de Heer EC; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands., Zois CE; Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk.; Department of Radiotherapy and Oncology, School of Health, Democritus University of Thrace, Alexandroupolis, Greece. christos.zois@oncology.ox.ac.uk.; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Molecular Oncology Laboratories, Oxford University, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk., Bridges E; Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, Oxford, OX3 9DS, UK., van der Vegt B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Sheldon H; Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, Oxford, OX3 9DS, UK., Veldman WA; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands., Zwager MC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van der Sluis T; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Morita T; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan., Baba O; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands.; Department of Medical Oncology, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands., de Jong S; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands., Harris AL; Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, Oxford, OX3 9DS, UK., Jalving M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands. m.jalving@umcg.nl.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Jun 06; Vol. 42 (1), pp. 143. Date of Electronic Publication: 2023 Jun 06.